US Stock MarketDetailed Quotes
VDRM ViaDerma, Inc.
- 0.005700
- +0.000100+1.79%
15min DelayClose Jul 5 16:00 ET
7.03MMarket Cap0.00P/E (TTM)
0.006700High0.005500Low923.37KVolume0.006700Open0.005600Pre Close5.47KTurnover0.08%Turnover Ratio0.00P/E (Static)1.23BShares0.01800052wk High0.00P/B7.03MFloat Cap0.00500052wk Low--Dividend TTM1.23BShs Float0.056900Historical High--Div YieldTTM21.43%Amplitude0.002000Historical Low0.005000Avg Price1Lot Size
ViaDerma, Inc. Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2012 | (Q1)Mar 31, 2012 | (FY)Dec 31, 2011 | (Q4)Dec 31, 2011 | (Q3)Sep 30, 2011 | (Q2)Jun 30, 2011 | (Q1)Mar 31, 2011 | (FY)Dec 31, 2010 | (Q4)Dec 31, 2010 | (Q3)Sep 30, 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.58%2.03M | 23.24%2M | -22.15%6.05M | -19.11%2.38M | -121.12%-200.28K | 21.90%2.25M | -20.36%1.63M | 135.10%7.78M | 116.53%2.94M | 6,029.74%948.33K |
| Operating gains losses | ---- | ---- | 8.21%1.54K | -373.95%-3.21K | --2.52K | --14 | --2.21K | -62.91%1.43K | 86.46%1.17K | ---- |
| Depreciation and amortization | 21.56%822K | 21.43%827.4K | 79.97%2.81M | 66.60%755.01K | 44.39%694.92K | 104.09%676.22K | 131.63%681.37K | 139.05%1.56M | 137.96%453.19K | 212.32%481.28K |
| Other non cash items | -10.43%954.83K | -38.30%401.36K | -50.20%2.67M | -51.93%534K | -69.23%422.28K | -59.54%1.07M | 161.04%650.48K | 921.68%5.37M | 227.56%1.11M | 512.40%1.37M |
| Change In working capital | -49.66%254.57K | 165.58%775.05K | -32.55%572.32K | -20.54%1.09M | -45.73%-1.32M | 260.34%505.7K | -57.81%291.84K | 131.41%848.45K | 249.41%1.38M | 45.84%-905.8K |
| -Change in receivables | -52.96%-816.96K | 125.25%238.52K | 567.42%618.62K | 297.32%1.51M | 2,280.93%591.14K | -2,138.67%-534.11K | -230.85%-944.49K | 103.66%92.69K | 479.20%379.06K | 98.28%-27.11K |
| -Change in inventory | -180.40%-277.84K | 120.62%84.21K | -7.14%-58.99K | -101.92%-9.52K | -52.86%13.34K | 208.78%345.55K | -56.35%-408.36K | -31.20%-55.06K | 167.01%495.48K | -81.01%28.29K |
| -Change in prepaid assets | 184.60%1.22M | -2,277.06%-1.39M | -1.93%615.18K | -111.09%-95.12K | 141.40%218.38K | 157.92%428K | -93.83%63.92K | 147.54%627.26K | 201.35%857.59K | -1,409.37%-527.47K |
| -Change in payables and accrued expense | -50.70%131.27K | 16.65%1.84M | -428.21%-602.49K | 13.44%-306.66K | -464.62%-2.14M | -68.00%266.26K | 1,755.37%1.58M | -85.87%183.57K | -718.73%-354.28K | -95.42%-379.52K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.58%2.03M | 23.24%2M | -22.15%6.05M | -19.11%2.38M | -121.12%-200.28K | 21.90%2.25M | -20.36%1.63M | 135.10%7.78M | 116.53%2.94M | 6,029.74%948.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 20.71%-2M | 30.19%-539.17K | -32.34%-9.43M | 55.57%-1.28M | -565.52%-4.86M | 28.46%-2.52M | -772.32K | -29.13%-7.12M | -0.27%-2.88M | 36.36%-730.43K |
| Net PPE purchase and sale | 20.71%-2M | 30.19%-539.17K | -32.34%-9.43M | 55.57%-1.28M | -565.52%-4.86M | 28.46%-2.52M | ---772.32K | -29.13%-7.12M | -0.27%-2.88M | 36.36%-730.43K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 20.71%-2M | 30.19%-539.17K | -32.34%-9.43M | 55.57%-1.28M | -565.52%-4.86M | 28.46%-2.52M | ---772.32K | -29.13%-7.12M | -0.27%-2.88M | 36.36%-730.43K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -544.99%-217.47K | 15.51%-674.94K | 762.44%2.95M | -272.48%-827.67K | 1,426.66%4.61M | 92.56%-33.72K | -540.52%-798.86K | -116.40%-445.95K | -71.40%479.86K | -151.53%-347.82K |
| Net issuance payments of debt | -652.96%-217.92K | -261.64%-144.89K | 2,431.86%3.15M | -227.36%-418.95K | 1,910.10%3.64M | 95.96%-28.94K | -108.83%-40.06K | -105.32%-134.99K | -89.13%328.95K | 35.83%-200.86K |
| Net other financing activities | 109.45%451 | 30.15%-530.05K | 37.76%-193.53K | -370.84%-408.72K | 765.97%978.75K | -101.81%-4.78K | -31.23%-758.79K | ---310.97K | --150.91K | -114.88%-146.97K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -544.99%-217.47K | 15.51%-674.94K | 762.44%2.95M | -272.48%-827.67K | 1,426.66%4.61M | 92.56%-33.72K | -540.52%-798.86K | -116.40%-445.95K | -71.40%479.86K | -151.53%-347.82K |
| Net cash flow | ||||||||||
| Beginning cash position | 32.31%1.37M | -40.54%578.49K | 25.16%972.89K | -32.35%302.23K | 31.16%746.54K | -61.56%1.04M | 25.16%972.89K | 189.30%777.33K | -26.96%446.76K | -46.80%569.2K |
| Current changes in cash | 40.34%-180.59K | 1,343.23%789.69K | -303.16%-419.83K | -49.71%275.19K | -244.07%-447.03K | 85.77%-302.72K | -97.15%54.72K | -59.48%206.66K | 224.02%547.17K | 71.59%-129.92K |
| Effect of exchange rate changes | -119.02%-2.61K | -75.83%1.92K | 329.18%25.44K | 105.08%1.07K | -63.68%2.72K | 491.45%13.7K | 5,168.21%7.96K | -680.52%-11.1K | -555.75%-21.04K | 1,032.29%7.48K |
| End cash Position | 58.99%1.19M | 32.31%1.37M | -40.54%578.49K | -40.54%578.49K | -32.35%302.23K | 31.16%746.54K | -61.56%1.04M | 25.16%972.89K | 25.16%972.89K | -26.96%446.76K |
| Free cash flow | 113.71%36.88K | 71.59%1.46M | -619.23%-3.38M | 1,559.26%1.1M | -2,433.19%-5.06M | 83.93%-269K | -58.19%853.57K | 129.38%650.56K | 104.37%66.23K | 119.16%216.93K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg